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Abstract
In tuning the sub-particle localisation of Gd(III) binding macrocycles within a mesoporous 
scaffold, nanoparticle contrast agents of unprecedented relaxivity and low Gd(III) loadings can be 
realised.
Magnetic resonance imaging (MRI) is a powerful non-invasive technique in medical 
research which becomes considerably more potent when magnetic contrast agents are 
applied to locally accelerate magnetic relaxation.1-4 Mesoporous silica structures, including 
those formed in the micro- and nano-size ranges have been generated by a variety of 
condensation and template assisted methods.5-7 Depending on their desired application, 
additional surface and pore modifications can be achieved by in situ co-condensation, post-
grafting or imprint coating.8 In tuning reaction conditions, these modifications can be biased 
towards either the internal or external surfaces.9,10 In recent years, significant effort has 
been invested in the incorporation of resonant contrast enhancing features into mesoporous 
silica nanoparticles (MSNs),11,12 which may be additionally modified with other modalities 
to augment their utility. The relaxation (and hence image contrast) offered by chelate 
entrapment within particles is generally enhanced in comparison to ‘molecular scale’ 
equivalents, an observation commonly assigned to the reduced tumbling rate associated with 
particles.13 The efficacy of internal water access in mesoporous materials has been noted 
experimentally and theoretically and is an important consideration in optimising 
paramagnetic contrast agent enhancement due to the complex dynamic processes occurring 
within porous channels.11,13-17 A number of methods by which Gd-chelates may be loaded 
into MSNs have been reported, including electrostatically driven layer-by-layer 
incorporation,18 direct coupling of the agent using silane chemistry,12,19,20 or carbodiimide 
linking through functional groups.11,13 In this communication, we describe the importance 
of Gd-chelate localisation and Gd loading in observed T1-weighted 1H MRI contrast and 
report the highest r1 relaxivities achieved to date with particles of this type.
MSNs were prepared herein using an aqueous Stöber technique employing a surfactant 
template which was subsequently removed to yield an internal hierarchical porous 
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network.5,21 The silanol-rich surfaces of the particles were partially aminated by either co-
condensing or post-grafting 3-aminopropyltriethoxysilane (APTES). Significantly, 
amination localisation could be controllably biased internally or externally by performing 
either time delayed co-condensation (Fig. 1a and b) or post-grafting (Fig. 1c),9,10 with 
retention of particle size (66.3 ± 6.6 nm), morphology and pore size (3.2 ± 1.3 nm) (Fig. S1, 
ESI†). These localisations subsequently act as anchor points for gadolinium-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl) triacetic acid (Gd-DOTA) attachment by standard 
chemical means to yield Gd-DOTA-functionalised MSNs (Gd-DOTA-MSNs) (see 
Experimental procedures and Fig. S2, ESI†).
The effects of preparation-tuned Gd-DOTA location bias on 1H spin-lattice MRI relaxivity 
were observed by monitoring the change in the relaxation rate (1/T1) per mM concentration 
of Gd on nanoparticulate samples at 7 T (Fig. 1). Notably, delayed co-condensation Gd-
DOTA-MSNs exhibited r1 relaxivities significantly higher (17.14 ± 0.49 mM−1 s−1 and 
33.57 ± 1.29 mM−1 s−1 for ‘short’ and ‘long delay’ reactions respectively) than those 
prepared by post-grafting (10.77 ± 0.22 mM−1 s−1). These relaxivities were, in the most 
optimised case, more than an order of magnitude greater than observed for molecular Gd-
DOTA at the same field (2.01 ± 0.14 mM−1 s−1), observations assignable to the markedly 
reduced rotational flexibility of the chelates when particle confined.13
The significant relaxivity enhancements observed for all co-condensation prepared Gd-
DOTA-MSNs equate with the internally biased location of the contrast agent chelates in 
such cases. The behaviour of mobile water confined within the porous networks of 
mesoporous silica is complex and influenced by molecular interactions with pore walls that 
reduce diffusive and rotational mobility compared to bulk water.15-17,22 This restricted 
innate water mobility, in combination with the internal wall confinement of paramagnetic 
centres, is expected to lead to markedly increased diffusional (τD) and rotational (τR) 
correlationtimes and altered characteristic water proton residence lifetime (τm).23-25 These 
effects serve to boost protic contrast and result in the remarkably high relaxivities observed. 
These confinement effects were additionally probed herein by investigation of the r1 
relaxivity of Gd-DOTA functionalised non-porous silica nanoparticles, prepared by post-
grafting. Such particles, with externally Gd-DOTA-loaded surfaces only, exhibit r1 
relaxivities of 9.56 ± 0.47 mM−1 s−1, very similar to those observed for post-grafted MSNs.
It is notable that the delayed co-condensation preparative technique used here provides a 
further refinement of relaxivity by enabling not only internal versus external control (of 
doped amine functionalities and hence Gd-chelate units) but also locality within the MSN 
interior. Specifically, an elongation of the delay leads to a higher probability of functional 
group distribution nearer to the nanoparticle porous openings, facilitating the correlation 
time advantages noted above with greater water accessibility and improved 1H relaxivity 
(‘long delay’ particles have relaxivities of 33.57 ± 1.29 mM−1 s−1 at 7 T). Gd-DOTA-MSNs 
prepared by ‘short delay’ co-condensation exhibited relaxivities of 17.14 ± 0.49 mM−1 s−1 at 
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7 T, indicative of more deeply internalised contrast agent groups, unable to undergo efficient 
water exchange with the external solvent.11,26
In addition to maximising contrast performance through localisation, we have examined the 
potential steric constraints on water access at high levels of Gd-DOTA loading (within 
particles otherwise optimised by ‘long delay’ co-condensation preparation). Specifically, 
samples with different percentage loadings of internalised Gd-DOTA contrast agents have 
been examined (Fig. 2 and S3, ESI†). All Gd-DOTA-MSN samples demonstrated significant 
relaxation enhancements compared to unbound Gd-DOTA complex in solution, as expected. 
On increasing loading from 1.37 wt% to 2.07 wt%, relaxivities were observed to drop from 
33.57 ± 1.29 mM−1 s−1 to 19.61 ± 1.51 mM−1 s−1 respectively, a downward trend which 
continued as loading was further increased to 3.82 wt% Gd (14.22 ± 0.67 mM−1 s−1). We 
assign these observations not only to the steric effects of increased macrocycle loading on 
water accessibility19,26 but also the progressive (sterically driven) bias of macrocycle 
loading towards the particle external surface at higher concentrations (where the advantages 
of water and Gd confinement are reduced).
Relaxivity assessments at (more clinically relevant) 3 T fields yielded r1 values of 39.26 ± 
1.29 mM−1 s−1 for the optimised 1.37 wt% Gd-DOTA-MSNs, a sensitisation which is 
unprecedented for nanoparticles based on a silica scaffold (prior reported relaxivities of Gd-
doped-MSNs span 6.2 to 28.8 mM−1 s−1 at 3 T; see Table S2, ESI†).12,19,26 Particularly 
striking in this work is the low level of Gd doping associated with these characteristics. 
These nanoparticle conjugates additionally exhibit excellent aqueous long-term colloidal, 
chemical (Fig. S4, ESI†) and contrast stability. Furthermore, since Gd loading is 
controllably internalised, the external particle surface can be biomodified with retention of 
high contrast (Fig. 2).27
Conclusions
In addition to their highly localised physicochemical characteristics and potentially 
increased blood circulation times, one of the principal advantages nanoparticle contrast 
agents have over their molecular analogues is their immensely high tunability. We have 
shown here that even very low levels of Gd-DOTA loading on the walls of mesoporous 
silica nanoparticles (1.37 wt% Gd, equivalent to 87 μmol g−1 of nanoparticles) can be 
effective in generating T1 MRI relaxation characteristics with some 20 fold enhancement 
over free Gd-DOTA (r1 = 39.26 ± 1.29 mM−1 s−1 [1.16 × 106 ± 3.82 × 104 per particle] at 3 
T and 33.57 ± 1.29 mM−1 s−1 [4.94 × 105 ± 8.03 × 103 per particle] at 7 T) and markedly 
higher than in any prior report at comparable field strengths. Central to this has been 
understanding and optimising the benefits of Gd internalisation on image contrast whilst 
maximising water exchange. The most promising aspect of utilising nanoparticles in 
diagnostic or theranostic applications remains an ability to engender high image contrast 
with additional functionality and low toxicity. We have shown herein that colloidally stable 
nanoparticles can be precisely engineered to have unprecedented relaxivities and exterior 
surfaces available for further functionalisation and bio-labelling.
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Fig. 1. 
Typical transmission electron microscope image and schematic representation of Gd-
DOTA-MSNs (66.3 ± 6.6 nm) prepared using (a) ‘Short delay’ co-condensation, where 
functionalities are internalised deeply in the structure (r1 = 17.14 ± 0.49 mM−1 s−1), (b) 
‘Long delay’ co-condensation, where functionalities are internalised nearer to the porous 
openings (r1 = 33.57 ± 1.29 mM−1 s−1) and (c) post-grafting, where functionalities are 
loaded on external surfaces (r1 = 10.77 ± 0.22 mM−1 s−1). (d) Post-grafted Gd-DOTA-non-
porous silica nanoparticles (r1 = 9.56 ± 0.47 mM−1 s−1). The chart displays r1 relaxivities of 
corresponding nanoparticle samples, measured at 7 T.
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Fig. 2. 
1H r1 relaxivities of Gd-DOTA complex in solution (2.01 ± 0.14 mM−1 s−1), Gd-DOTA-
MSNs prepared with different percentage Gd loadings (1.37 wt% Gd: 33.57 ± 1.29 mM−1 
s−1; 2.07 wt% Gd: 19.61 ± 1.51 mM−1 s−1; 3.82 wt% Gd: 14.22 ± 0.67 mM−1 s−1) and 
biomodified Gd-DOTA-MSNs (26.69 ± 0.43 mM−1 s−1),27 measured at 7 T. Upper inset 
shows corresponding T1-weighted phantom images of aqueous MSN samples with [Gd] 0.04 
mM (TR = 30 ms; TE = 5 ms; slice thickness = 2 mm; matrix = 256 × 256, at 20 ° C).
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